XTANDI Reviews (ENZALUTAMIDE)

Average Rating: 2.5 (4 Ratings)

Filter Results

Compare XTANDI with similar:

 Type: Rx Drug

  

XTANDI  (ENZALUTAMIDE):  Enzalutamide is used to treat men with a certain type of prostate cancer. This type of prostate cancer has not responded to other treatments to lower the male hormone testosterone. This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.   FDA Approval Date: 2012-08-31 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR XTANDICOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  Prostate CA Extreme tiredness and lassitude. Couldn't get out of bed several times. Dry mouth and altered taste of food and beverages. Was put on this medication as my PSA was rising. This drug is truly awful, making it made me into a zombie with no energy to get out of bed several times. or do minimal tasks around the house. Killed my appetite producing a most unpleasant tast and dryness in my mouth. I stopped it and won't go back on it no matter what. M 85 1 months
160 1X day
3/14/2024
Email
 3  Prostate Cancer onset Insomnia is hell when taking 4 tabs a day got better when i reduced the dose. M 68 3 months
30 1X day
10/19/2023
 5  castrate resistant prostate cancer 69
160 mg 1X day
7/17/2021
Patient History
 1  Prostate cancer Piece of crap drug it does not work. Junk drug and a big ripoff The drug does not work piece of crap. Got off the drug and my psa went down M 72 100 days
160 mg 1X day
10/28/2020
Email
  

XTANDI  (ENZALUTAMIDE):  Enzalutamide is used to treat men with a certain type of prostate cancer. This type of prostate cancer has not responded to other treatments to lower the male hormone testosterone. This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.   FDA Approval Date: 2012-08-31 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP